Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,054,497
+$656,541 QoQ
Shares Held
12,027
+22.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#1,993
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trivium Point Advisory, LLC holds $28,456,605 across 8 Drug Manufacturers - General names. JNJ ranks #2 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,340 | $16,000,397 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
12,027 | $3,054,497 | |
| 3 | ABBV |
AbbVie Inc.
|
10,728 | $2,699,593 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,671 | $2,270,723 | |
| 5 | AMGN |
Amgen Inc
|
3,478 | $1,259,453 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
20,481 | $1,180,115 | |
| 7 | PFE |
Pfizer Inc
|
45,408 | $1,093,424 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,111 | $898,403 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,054,497 | 12,027 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,397,956 | 9,810 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,479,881 | 11,983 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,142,342 | 11,554 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,715,535 | 11,231 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,674,984 | 10,100 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,356,246 | 9,378 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,215,450 | 7,500 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,096,784 | 7,504 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,085,816 | 6,864 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,034,797 | 6,602 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,043,836 | 6,702 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,111,797 | 6,717 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,051,985 | 6,787 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $1,245,735 | 7,052 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,152,014 | 7,052 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,283,574 | 7,231 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,426,701 | 8,050 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,310,225 | 7,659 | Shares | Sole | 2022-02-18 | |
| 2021-09-30 | $222,708 | 1,379 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,766,314 | 16,792 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,680,055 | 16,307 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,515,404 | 15,983 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,430,019 | 16,322 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,263,861 | 16,098 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,070,542 | 15,790 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||